Darakjian Erin 4
4 · P3 Health Partners Inc. · Filed Nov 30, 2022
Insider Transaction Report
Form 4
Darakjian Erin
Interim CFO, Senior VP & CAO
Transactions
- Award
Stock Option (Right to Buy)
2022-11-28+100,000→ 100,000 totalExercise: $4.62Exp: 2032-11-28→ Class A Common Stock (100,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable with respect to 25% of the shares on each of October 18, 2023, October 18, 2024, October 18, 2025 and October 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date.